SGL Investment Advisors Inc. Acquires 39 Shares of Intuitive Surgical, Inc. $ISRG

SGL Investment Advisors Inc. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 751 shares of the medical equipment provider’s stock after acquiring an additional 39 shares during the period. SGL Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $396,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Shell Asset Management Co. lifted its position in shares of Intuitive Surgical by 22.7% in the 2nd quarter. Shell Asset Management Co. now owns 32,349 shares of the medical equipment provider’s stock worth $17,579,000 after purchasing an additional 5,984 shares during the period. Joel Isaacson & Co. LLC raised its stake in Intuitive Surgical by 1.5% in the second quarter. Joel Isaacson & Co. LLC now owns 2,632 shares of the medical equipment provider’s stock worth $1,430,000 after buying an additional 38 shares in the last quarter. Roundview Capital LLC lifted its holdings in Intuitive Surgical by 37.1% in the second quarter. Roundview Capital LLC now owns 14,385 shares of the medical equipment provider’s stock worth $7,817,000 after buying an additional 3,894 shares during the period. True Vision MN LLC boosted its position in Intuitive Surgical by 3.0% during the 2nd quarter. True Vision MN LLC now owns 766 shares of the medical equipment provider’s stock valued at $416,000 after acquiring an additional 22 shares in the last quarter. Finally, KLP Kapitalforvaltning AS grew its holdings in shares of Intuitive Surgical by 3.9% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 127,962 shares of the medical equipment provider’s stock worth $69,536,000 after acquiring an additional 4,800 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.6%

Shares of ISRG opened at $449.69 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market capitalization of $161.20 billion, a P/E ratio of 62.72, a price-to-earnings-growth ratio of 4.74 and a beta of 1.61. The firm has a 50 day moving average of $462.67 and a 200 day moving average of $499.82.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s revenue was up 21.4% compared to the same quarter last year. During the same period last year, the business posted $1.78 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ISRG shares. Royal Bank Of Canada restated an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Truist Financial upped their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Evercore ISI increased their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Piper Sandler reissued an “overweight” rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.